1![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRESIBA® safely and effectively. See full prescribing information for TRESIBA®. TRESIBA® (insulin degludec inject HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRESIBA® safely and effectively. See full prescribing information for TRESIBA®. TRESIBA® (insulin degludec inject](https://www.pdfsearch.io/img/56454a5304fd02dba11c5faa9268f46f.jpg) | Add to Reading ListSource URL: www.novo-pi.com- Date: 2016-12-20 16:52:45
|
---|
2![INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr](https://www.pdfsearch.io/img/c0ed0fef081a852e8bd3f77abaa4b9a0.jpg) | Add to Reading ListSource URL: sgedssed.chLanguage: German - Date: 2015-10-08 11:33:08
|
---|
3![This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap](https://www.pdfsearch.io/img/08dc901a195b4b27a5dbd6d0b8ab40f3.jpg) | Add to Reading ListSource URL: www.novonordisk.caLanguage: English - Date: 2016-08-18 19:09:23
|
---|
4![Tresiba, INN-insulin degludec Tresiba, INN-insulin degludec](https://www.pdfsearch.io/img/35201c6f571330de5f16de5c7e36f04a.jpg) | Add to Reading ListSource URL: www.ema.europa.eu- Date: 2013-07-21 06:39:48
|
---|
5![fact file 18 New Insulins Scientific and technical advances in recent years have driven the development of a number of human and analogue insulins with better clinical and pharmacological properties Dr Victoria Stokes, S fact file 18 New Insulins Scientific and technical advances in recent years have driven the development of a number of human and analogue insulins with better clinical and pharmacological properties Dr Victoria Stokes, S](https://www.pdfsearch.io/img/c5e4bcfe24dc8135e94a28dc3abc4fc1.jpg) | Add to Reading ListSource URL: www.diabetes.org.ukLanguage: English - Date: 2014-03-27 10:01:20
|
---|
6![Ryzodeg® (insulin degludec/insulin aspart) passed the review by the First Committee on Drugs of Pharmaceutical Affairs in Japan Bagsværd, Denmark, 3 December 2012 – Novo Nordisk today announced that Ryzodeg® (insuli Ryzodeg® (insulin degludec/insulin aspart) passed the review by the First Committee on Drugs of Pharmaceutical Affairs in Japan Bagsværd, Denmark, 3 December 2012 – Novo Nordisk today announced that Ryzodeg® (insuli](https://www.pdfsearch.io/img/48048ba804081e9715d35f46c15790bb.jpg) | Add to Reading ListSource URL: hugin.infoLanguage: English - Date: 2012-12-03 01:33:41
|
---|
7![INSULINE TRESIBA – PRISE DE POSITION DE LA SSED L’insulin degludec (Tresiba) est une insuline de longue durée d’action autorisée en Suisse et en Europe. Elle n’est par contre actuellement pas enregistrée sur INSULINE TRESIBA – PRISE DE POSITION DE LA SSED L’insulin degludec (Tresiba) est une insuline de longue durée d’action autorisée en Suisse et en Europe. Elle n’est par contre actuellement pas enregistrée sur](https://www.pdfsearch.io/img/b184c2b618263d31fd973000f433e354.jpg) | Add to Reading ListSource URL: www.sgedssed.chLanguage: French - Date: 2014-06-30 07:19:06
|
---|
8![INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr](https://www.pdfsearch.io/img/f7735201c10c74b856564eaf5ef80182.jpg) | Add to Reading ListSource URL: www.sgedssed.chLanguage: German - Date: 2014-07-01 04:41:46
|
---|
9![Introduction: Degludec and Degludec/Aspart Endocrinologic and Metabolic Drugs Advisory Committee Meeting November 8, 2012 Jean-Marc Guettier, MDCM Introduction: Degludec and Degludec/Aspart Endocrinologic and Metabolic Drugs Advisory Committee Meeting November 8, 2012 Jean-Marc Guettier, MDCM](https://www.pdfsearch.io/img/e9999bc3d6b579f7d8d78f7308705b4a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![Microsoft Word - DRAFT Questions EMDAC[removed]docx Microsoft Word - DRAFT Questions EMDAC[removed]docx](https://www.pdfsearch.io/img/db1eabca6e5b3020e553e5acb1a30e27.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|